Tocilizumab-Induced Unexpected Increase of Several Inflammatory Cytokines in Critically Ill COVID-19 Patients: The Anti-Inflammatory Side of IL-6
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tocilizumab-Induced Unexpected Increase of Several Inflammatory Cytokines in Critically Ill COVID-19 Patients: The Anti-Inflammatory Side of IL-6
Authors
Keywords
-
Journal
VIRAL IMMUNOLOGY
Volume 35, Issue 1, Pages 60-70
Publisher
Mary Ann Liebert Inc
Online
2022-01-28
DOI
10.1089/vim.2021.0111
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Biomarkers for Early Diagnosis of Hemophagocytic Lymphohistiocytosis in Critically Ill Patients
- (2021) France Debaugnies et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Cytokine Profiles Before and After Immune Modulation in Hospitalized Patients with COVID-19
- (2021) Veronica Azmy et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19
- (2021) NEW ENGLAND JOURNAL OF MEDICINE
- Therapeutic Role of Tocilizumab in SARS-CoV-2-Induced Cytokine Storm: Rationale and Current Evidence
- (2021) Corrado Pelaia et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Discrimination of COVID‐19 from inflammation‐induced cytokine storm syndromes by disease‐related blood biomarkers
- (2021) Christoph Kessel et al. Arthritis & Rheumatology
- Interleukin-6 receptor blockade in patients with COVID-19: placing clinical trials into context
- (2021) Federico Angriman et al. Lancet Respiratory Medicine
- Connecting With Patients—The Missing Links
- (2020) Lisa Sanders et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Metta-based group meditation and individual cognitive behavioral therapy (MeCBT) for chronic depression: study protocol for a randomized controlled trial
- (2020) Artjom Frick et al. Trials
- Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy
- (2020) Paola Toniati et al. AUTOIMMUNITY REVIEWS
- Translating IL-6 biology into effective treatments
- (2020) Ernest H. Choy et al. Nature Reviews Rheumatology
- A Comprehensive Review of Tocilizumab in COVID‐19 Acute Respiratory Distress Syndrome
- (2020) Sajad Khiali et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report
- (2020) NEW ENGLAND JOURNAL OF MEDICINE
- Cytokine Storm in COVID-19: The Current Evidence and Treatment Strategies
- (2020) Yujun Tang et al. Frontiers in Immunology
- Comparative Survival Analysis of Immunomodulatory Therapy for COVID-19 'Cytokine Storm'
- (2020) Sonali Narain et al. CHEST
- Targeting pivotal inflammatory pathways in COVID-19: A mechanistic review
- (2020) Akram Yarmohammadi et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Confronting the controversy: interleukin-6 and the COVID-19 cytokine storm syndrome
- (2020) Luke Y.C. Chen et al. EUROPEAN RESPIRATORY JOURNAL
- Low-dose hydroxychloroquine therapy and mortality in hospitalised patients with COVID-19: a nationwide observational study of 8075 participants
- (2020) Lucy Catteau et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- IL-6 serum levels predict severity and response to tocilizumab in COVID-19: An observational study
- (2020) José María Galván-Román et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- An inflammatory cytokine signature predicts COVID-19 severity and survival
- (2020) Diane Marie Del Valle et al. NATURE MEDICINE
- Efficacy of Tocilizumab in Patients Hospitalized with Covid-19
- (2020) John H. Stone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes
- (2020) Daniel E Leisman et al. Lancet Respiratory Medicine
- A “Window of Therapeutic Opportunity” for Anti-Cytokine Therapy in Patients With Coronavirus Disease 2019
- (2020) Ludovico De Stefano et al. Frontiers in Immunology
- Interleukin-6: designing specific therapeutics for a complex cytokine
- (2018) Christoph Garbers et al. NATURE REVIEWS DRUG DISCOVERY
- Therapeutic blockade of the interleukin-6 receptor (IL-6R) allows sIL-6R generation by proteolytic cleavage
- (2018) Niklas Prenissl et al. CYTOKINE
- Tocilizumab (Actemra)
- (2017) Martin Sheppard et al. Human Vaccines & Immunotherapeutics
- Interleukin-6 and its receptors: A highly regulated and dynamic system
- (2014) Janina Wolf et al. CYTOKINE
- IL-6 biology: implications for clinical targeting in rheumatic disease
- (2014) Leonard H. Calabrese et al. Nature Reviews Rheumatology
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation